Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: JAMA Cardiol. 2016 Apr 1;1(1):37–45. doi: 10.1001/jamacardio.2015.0275

Table 1.

Variation in Adherence to Individual Guideline Recommended Process Measures by Hospital Quartile Composite Performance

Overall 1st Quartilea (Lowest) 2nd Quartilea 3rd Quartilea 4th Quartilea (Highest) p-value
(n=35,283) (n=4,576) (n=7,883) (n=10,900) (n=11,924)
Device confirmation of correct endotracheal tube placement
 Eligible patients 16,572 (47.0) 2,380 (52.0) 3,996 (50.7) 4,797 (44.0) 5,399 (45.3) 0.17
 Received measure 14,217 (85.8) 1,684 (70.8) 3,126 (78.2) 4,317 (90.0) 5,090 (94.3)
Percent pulseless cardiac events monitored or witnessed
 Eligible patients 32,014 (90.7) 4,057 (88.7) 7,121 (90.3) 10,009 (91.8) 10,827 (90.8) 0.36
 Received measure 30,093 (94.0) 3,627 (89.4) 6,574 (92.3) 9,413 (94.0) 10,479 (96.8)
Time to first chest compressions ≤1 min
 Eligible patients 34,215 (97.0) 4,359 (95.3) 7,624 (96.7) 10,471 (96.1) 11,761 (98.6) 0.18
 Received measure 32,607 (95.3) 3,915 (89.8) 7,105 (93.2) 10,038 (95.9) 11,549 (98.2)
Time to first shock ≤2 mins for VF/VT
 Eligible patients 5,113 (14.5) 684 (14.9) 1,156 (14.7) 1,563 (14.3) 1,710 (14.3) 0.08
 Received measure 3,051 (59.7) 338 (49.4) 649 (56.1) 926 (59.2) 1,138 (66.5)
Time to IV/IO epinephrine/vasopressin bolus administered to pulseless adults ≤5 mins
 Eligible patients 22,003 (62.4) 2,599 (56.8) 4,675 (59.3) 7,088 (65.0) 7,641 (64.1) 0.14
 Received measure 19,731 (89.7) 2,148 (82.6) 4,107 (87.9) 6,353 (89.6) 7,123 (93.2)

Abbreviations: ET, endotracheal tube; IQR, interquartile range; IV/IO, intravenous/intraosseous; min, minutes; VF/VT, ventricular fibrillation/ventricular tachycardia

a

Quartiles are divided into equal hospital quartiles based on sequentially ordered composite quality performance scores.